Total Voting Rights

Summary by AI ^BETAClose X

The Schiehallion Fund Limited has announced that as of November 30, 2025, its total issued share capital comprises 1,025,203,907 ordinary shares, with 12,170,000 shares held in treasury. Consequently, the total number of voting rights available to shareholders is 1,013,033,907. This figure serves as the denominator for shareholders to determine their notification obligations under the FCA's Disclosure Guidance and Transparency Rules regarding their interests in the company.

Disclaimer*

Schiehallion Fund Limited (The)

01 December 2025

The Schiehallion Fund Limited (MNTN)

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

Voting Rights and Capital

In conformity with Disclosure Guidance and Transparency Rule 5.6.1.R we would like to notify the market of the following:

The Schiehallion Fund Limited (MNTN) capital consists of 1,025,203,907 ordinary shares. The Schiehallion Fund Limited holds 12,170,000 ordinary shares in Treasury. Therefore, the total number of voting rights in The Schiehallion Fund Limited is 1,013,033,907 as at 30 November 2025.

The above figure (1,013,033,907) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, The Schiehallion Fund Limited under the FCA's Disclosure Guidance and Transparency Rules.

Baillie Gifford & Co Limited

1 December 2025

Regulated Information Classification: Total number of voting rights and capital

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END